Candidiasis – mycolab.ai

Spatial distribution of pathogenic fungal isolates from clinical samples in Uganda: Diagnostic gaps and trends, January 2020 – May 2024

mycolabadmin

This study examined fungal infections detected in Uganda’s laboratories from 2020 to 2024, finding that common yeast infections called Candida were the most frequently identified. Most cases occurred in women aged 16-35 years, particularly in the cities of Kampala and Mbarara. The research reveals that Uganda’s laboratories can only identify two types of fungi and cannot test which medications work best against them, highlighting the need for better diagnostic tools and training.

A Case Report of Candidiasis Cellulitis in Long-Term Corticosteroid Use

mycolabadmin

A 54-year-old man developed a serious skin infection on his hand caused by Candida, a normally harmless fungus, because he had been taking corticosteroid injections for 15 years for breathing problems. Despite antibiotic treatment, the swelling and pain continued. Doctors discovered it was a fungal infection through lab tests and treated it with antifungal medication (fluconazole) after draining the infection, which completely healed within two weeks.

Fungal Infections – a Stealthy Enemy in Patients with Chronic Granulomatous Disease: a 28-years’ Experience from North India

mycolabadmin

Patients with chronic granulomatous disease (CGD), a rare immune system disorder, are highly susceptible to serious fungal infections. This study of 99 patients over 28 years found that 40% developed fungal infections, mostly caused by Aspergillus fungi affecting the lungs. These infections were life-threatening, with over half the infected patients dying despite aggressive treatment with antifungal medications. Doctors need to screen for fungal infections early, even in patients without obvious symptoms, and treat infants and males more aggressively.

Superficial Fungal Infections in Children—What Do We Know?

mycolabadmin

Superficial fungal infections like ringworm and athlete’s foot are common in children and are caused by fungi, yeasts, or molds that spread through contact with infected people, animals, or contaminated surfaces. These infections primarily affect the scalp, skin, and nails, with scalp infections being most common in young children. Treatment typically uses topical creams for mild cases or oral medications for more severe infections, particularly those affecting nails or the scalp. Proper hygiene, avoiding contaminated areas, and limiting contact with infected individuals or animals are key to prevention.

Genomic Insights of Candida krusei, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance

mycolabadmin

Candida krusei is a yeast that causes serious bloodstream infections, particularly in people with weakened immune systems. Unlike many other fungi, it naturally resists common antifungal drugs like fluconazole, making infections hard to treat. The organism can form protective biofilms and has multiple genetic mechanisms that help it survive antifungal treatment. Researchers are exploring new drugs and treatment strategies to combat this growing health threat, especially in hospitals.

Increasing postgraduate medical mycology research dissertations at Uganda’s higher institution of learning

mycolabadmin

This study shows how providing research funding helped increase medical mycology studies at a Ugandan university. Over just two years, the percentage of graduate student research focused on fungal diseases jumped from 16% to 40%. Students studied important fungal infections like cryptococcal meningitis and candida, using modern laboratory techniques. The research group’s collaborative learning approach and financial support enabled students to complete their studies on time and advance understanding of fungal diseases that significantly impact public health.

Recent innovations and challenges in the treatment of fungal infections

mycolabadmin

Fungal infections are becoming more common and harder to treat due to drug resistance, especially in people with weakened immune systems. Current antifungal medications are becoming less effective because fungi are adapting to resist them, and these drugs can cause serious side effects. Scientists are developing new treatment strategies using combinations of existing drugs, engineered biological approaches, and specially designed delivery systems to overcome resistance and improve patient outcomes.

A Case Report of Candidiasis Cellulitis in Long-Term Corticosteroid Use

mycolabadmin

A 54-year-old man developed a serious hand infection caused by Candida albicans, a yeast that normally lives harmlessly on human skin. The infection occurred because he had been taking large doses of corticosteroid injections for 15 years to help with breathing problems, which weakened his immune system. Doctors drained the infected area and treated him with antifungal medication, and he recovered completely, highlighting the importance of recognizing fungal infections in patients on long-term steroid therapy.

Candida albicans bloodstream infections are comprised of diverse populations of strains, including antifungal tolerant strains that emerge during treatment failure

mycolabadmin

Researchers found that Candida albicans bloodstream infections contain multiple different strains, not just one strain as previously thought. Some strains are more tolerant to antifungal medications like micafungin, and when treatment is started, the drug-tolerant strains can be eliminated while drug-sensitive strains increase in number. This discovery suggests that treatment failures may occur because pre-existing drug-resistant strains are selected for during treatment.

Abundant Yet Aberrant T Helper Cell Responses to Candida albicans Underlie Mucosal Candidiasis in Humans and Mice

mycolabadmin

Researchers studied how the immune system fights Candida albicans fungal infections. They found that a specific type of immune cell called Th17 cells is absolutely essential for controlling these infections, while other immune cells called Th2 cells actually make infections worse by blocking the protective Th17 cells. Patients with certain genetic mutations that affect how their immune system works have too many Th2 cells and not enough Th17 cells, making them vulnerable to chronic fungal infections. The study suggests that blocking a molecule called IL-4 could help restore the balance and improve patient outcomes.

Research Topic: Candidiasis